Cryocell International Stock Performance
| CCEL Stock | USD 8.45 0.65 8.33% |
On a scale of 0 to 100, CryoCell International holds a performance score of 15. The firm shows a Beta (market volatility) of 0.67, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CryoCell International's returns are expected to increase less than the market. However, during the bear market, the loss of holding CryoCell International is expected to be smaller as well. Please check CryoCell International's skewness, and the relationship between the potential upside and rate of daily change , to make a quick decision on whether CryoCell International's price patterns will revert.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CryoCell International are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady technical and fundamental indicators, CryoCell International disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.71) | Five Day Return 8.96 | Year To Date Return 44.66 | Ten Year Return 315.23 | All Time Return 67.8 |
Dividend Date 2022-09-09 | Ex Dividend Date 2022-09-01 |
1 | Acquisition by Jonathan Wheeler of 7500 shares of CryoCell International subject to Rule 16b-3 | 02/09/2024 |
2 | CryoCell International earnings missed by 1.27, revenue fell short of estimates - Investing.com South Africa | 02/29/2024 |
3 | Short Interest in Cryo-Cell International, Inc. Expands By 140.9 percent - MarketBeat | 03/28/2024 |
4 | Acquisition by David Portnoy of 3850 shares of CryoCell International at 4.9 subject to Rule 16b-3 | 04/02/2024 |
5 | Disposition of 100000 shares by Mark Portnoy of CryoCell International at 12.27 subject to Rule 16b-3 | 04/11/2024 |
6 | Acquisition by Jonathan Wheeler of 7500 shares of CryoCell International at 3.08 subject to Rule 16b-3 | 04/23/2024 |
| Begin Period Cash Flow | 1.7 M |
CryoCell |
CryoCell International Relative Risk vs. Return Landscape
If you would invest 520.00 in CryoCell International on January 30, 2024 and sell it today you would earn a total of 325.00 from holding CryoCell International or generate 62.5% return on investment over 90 days. CryoCell International is currently generating 0.8657% in daily expected returns and assumes 4.3953% risk (volatility on return distribution) over the 90 days horizon. In different words, 38% of stocks are less volatile than CryoCell, and 83% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CryoCell International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CryoCell International's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CryoCell International, and traders can use it to determine the average amount a CryoCell International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.197
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CCEL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.4 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.87 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average CryoCell International is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CryoCell International by adding it to a well-diversified portfolio.
CryoCell International Fundamentals Growth
CryoCell Stock prices reflect investors' perceptions of the future prospects and financial health of CryoCell International, and CryoCell International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CryoCell Stock performance.
| Return On Equity | 1.29 | ||||
| Return On Asset | -0.0093 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 78.5 M | ||||
| Shares Outstanding | 8.1 M | ||||
| Price To Earning | 10.76 X | ||||
| Price To Book | 9.72 X | ||||
| Price To Sales | 1.91 X | ||||
| Revenue | 31.34 M | ||||
| Gross Profit | 21.54 M | ||||
| EBITDA | 5.2 M | ||||
| Net Income | (9.52 M) | ||||
| Cash And Equivalents | 2.96 M | ||||
| Cash Per Share | 0.35 X | ||||
| Total Debt | 10.9 M | ||||
| Debt To Equity | 0.26 % | ||||
| Current Ratio | 0.47 X | ||||
| Book Value Per Share | (1.25) X | ||||
| Cash Flow From Operations | 8.92 M | ||||
| Earnings Per Share | (1.16) X | ||||
| Market Capitalization | 68.48 M | ||||
| Total Asset | 61.22 M | ||||
| Retained Earnings | (31.16 M) | ||||
| Working Capital | (11.41 M) | ||||
| Current Asset | 6.08 M | ||||
| Current Liabilities | 2.82 M | ||||
About CryoCell International Performance
To evaluate CryoCell International Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when CryoCell International generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare CryoCell Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand CryoCell International market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents CryoCell's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 38.23 | 36.32 | |
| Return On Tangible Assets | (0.15) | (0.14) | |
| Return On Capital Employed | (0.27) | (0.26) | |
| Return On Assets | (0.14) | (0.15) | |
| Return On Equity | 0.99 | 1.04 |
Things to note about CryoCell International performance evaluation
Checking the ongoing alerts about CryoCell International for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CryoCell International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CryoCell International appears to be risky and price may revert if volatility continues | |
| The company currently holds 10.9 M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. CryoCell International has a current ratio of 0.46, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist CryoCell International until it has trouble settling it off, either with new capital or with free cash flow. So, CryoCell International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CryoCell International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CryoCell to invest in growth at high rates of return. When we think about CryoCell International's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 31.34 M. Net Loss for the year was (9.52 M) with profit before overhead, payroll, taxes, and interest of 21.54 M. | |
| CryoCell International has a poor financial position based on the latest SEC disclosures | |
| About 47.0% of CryoCell International shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Jonathan Wheeler of 7500 shares of CryoCell International at 3.08 subject to Rule 16b-3 |
- Analyzing CryoCell International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CryoCell International's stock is overvalued or undervalued compared to its peers.
- Examining CryoCell International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CryoCell International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CryoCell International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CryoCell International's stock. These opinions can provide insight into CryoCell International's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.Note that the CryoCell International information on this page should be used as a complementary analysis to other CryoCell International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for CryoCell Stock analysis
When running CryoCell International's price analysis, check to measure CryoCell International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoCell International is operating at the current time. Most of CryoCell International's value examination focuses on studying past and present price action to predict the probability of CryoCell International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoCell International's price. Additionally, you may evaluate how the addition of CryoCell International to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is CryoCell International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Earnings Share (1.16) | Revenue Per Share 3.783 | Quarterly Revenue Growth 0.004 | Return On Assets (0.01) |
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.